Effect of liraglutide on atherosclerosis in patients with impaired glucose tolerance: A double‑blind, randomized controlled clinical trial
Author:
Affiliation:
1. Department of Endocrinology, Chengyang People's Hospital in Qingdao, Qingdao, Shandong 266109, P.R. China
2. Department of Pharmacy, Chengyang People's Hospital in Qingdao, Qingdao, Shandong 266109, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine
Reference54 articles.
1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition;Saeedi;Diabetes Res Clin Pract,2019
2. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study;de Vegt;JAMA,2001
3. Impaired glucose tolerance in the U.S. population;Harris;Diabetes Care,1989
4. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies;Edelstein;Diabetes,1997
5. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis;Huang;BMJ,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13
2. Preparation and characterization of BSA-loaded liraglutide and platelet fragment nanoparticle delivery system for the treatment of diabetic atherosclerosis;Journal of Nanobiotechnology;2024-08-23
3. Liraglutide’s Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis;Endocrine Practice;2024-08
4. From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists;Molecular Biology Reports;2024-07-23
5. Preparation and characterization of BSA-loaded Liraglutide and platelet fragment nanoparticle delivery system for the treatment of diabetic atherosclerosis;2024-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3